Abstract
This Frost & Sullivan research service titled Advances in Stent Technologies
provides the reader with an overview of the drug eluting stent industry, talks
about the present day challenges alongside the drivers that drive the growth
of the DES business. In addition, it provides readers with packets of
information on emerging technologies in the DES space and the new
bioabsorbable stent, which is set to revolutionize the stent business. In this
research, Frost & Sullivan' s expert analysts thoroughly examine the following
stent technologies: drug eluting, and bioabsorbable.
This analysis is available through our Technical Insights Growth Partnership
Service program. With this program, clients receive industry-leading market
research such as this, along with technical and econometric data and many
interactive features including Analyst Inquiry Time and Client Councils.